• 1
    Jones PA,Baylin SB. The epigenomics of cancer. Cell 2007; 128: 68392.
  • 2
    Ushijima T,Sasako M. Focus on gastric cancer. Cancer Cell 2004; 5: 1215.
  • 3
    Issa JP,Ottaviano YL,Celano P,Hamilton SR,Davidson NE,Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 53640.
  • 4
    Ushijima T,Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci 2005; 96: 20611.
  • 5
    Maekita T,Nakazawa K,Mihara M,Nakajima T,Yanaoka K,Iguchi M,Arii K,Kaneda A,Tsukamoto T,Tatematsu M,Tamura G,Saito D, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12: 98995.
  • 6
    Nakajima T,Maekita T,Oda I,Gotoda T,Yamamoto S,Umemura S,Ichinose M,Sugimura T,Ushijima T,Saito D. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 231721.
  • 7
    Kaneda A,Kaminishi M,Yanagihara K,Sugimura T,Ushijima T. Identification of silencing of nine genes in human gastric cancers. Cancer Res 2002; 62: 664550.
  • 8
    Yamashita S,Tsujino Y,Moriguchi K,Tatematsu M,Ushijima T. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 2006; 97: 6471.
  • 9
    Kaneda A,Kaminishi M,Sugimura T,Ushijima T. Decreased expression of the seven ARP2/3 complex genes in human gastric cancers. Cancer Lett 2004; 212: 203210.
  • 10
    Weber M,Hellmann I,Stadler MB,Ramos L,Paabo S,Rebhan M,Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007; 39: 45766.
  • 11
    Li B,Carey M,Workman JL. The role of chromatin during transcription. Cell 2007; 128: 70719.
  • 12
    Lin JC,Jeong S,Liang G,Takai D,Fatemi M,Tsai YC,Egger G,Gal-Yam EN,Jones PA. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 2007; 12: 43244.
  • 13
    Hsieh CJ,Klump B,Holzmann K,Borchard F,Gregor M,Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998; 58: 394245.
  • 14
    Issa JP,Ahuja N,Toyota M,Bronner MP,Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61: 357377.
  • 15
    Kondo Y,Kanai Y,Sakamoto M,Mizokami M,Ueda R,Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 2000; 32: 9709.
  • 16
    Hussain SP,Harris CC. Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutat Res 2000; 462: 31122.
  • 17
    Toyota M,Ushijima T,Kakiuchi H,Canzian F,Watanabe M,Imai K,Sugimura T,Nagao M. Genetic alterations in rat colon tumors induced by heterocyclic amines. Cancer 1996; 77: 159397.
  • 18
    Uemura N,Okamoto S,Yamamoto S,Matsumura N,Yamaguchi S,Yamakido M,Taniyama K,Sasaki N,Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 19
    Leung WK,Man EP,Yu J,Go MY,To KF,Yamaoka Y,Cheng VY,Ng EK,Sung JJ. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 2006; 12: 321621.
  • 20
    Chan AO,Chu KM,Huang C,Lam KF,Leung SY,Sun YW,Ko S,Xia HH,Cho CH,Hui WM,Lam SK,Rashid A. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 2007; 56: 5957.
  • 21
    Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000; 53: 25561.
  • 22
    Tsugane S,Sasazuki S,Kobayashi M,Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer 2004; 90: 12834.
  • 23
    Kawakami Y,Akahane T,Gotoh A,Okimura Y,Oana K,Katsuyama T. Successful development of air-dried microplates (HP-Plates) for susceptibility testing against Helicobacter pylori isolates. Microbiol Immunol 1997; 41: 70308.
  • 24
    Nishikawa K,Sugiyama T,Kato M,Ishizuka J,Kagaya H,Hokari K,Asaka M. A prospective evaluation of new rapid urease tests before and after eradication treatment of Helicobacter pylori, in comparison with histology, culture and 13C-urea breath test. Gastrointest Endosc 2000; 51: 1648.
  • 25
    Kosunen TU,Seppala K,Sarna S,Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of. Helicobacter pylori. Lancet 1992; 339: 8935.
  • 26
    Marchildon P,Balaban DH,Sue M,Charles C,Doobay R,Passaretti N,Peacock J,Marshall BJ,Peura DA. Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 210508.
    Direct Link:
  • 27
    De Smet C,Loriot A,Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 2004; 24: 478190.
  • 28
    Song JZ,Stirzaker C,Harrison J,Melki JR,Clark SJ. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 2002; 21: 104861.
  • 29
    Hagihara A,Miyamoto K,Furuta J,Hiraoka N,Wakazono K,Seki S,Fukushima S,Tsao MS,Sugimura T,Ushijima T. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 2004; 23: 870510.
  • 30
    Furuta J,Nobeyama Y,Umebayashi Y,Otsuka F,Kikuchi K,Ushijima T. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res 2006; 66: 608086.
  • 31
    Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005; 5: 22331.
  • 32
    Keshet I,Schlesinger Y,Farkash S,Rand E,Hecht M,Segal E,Pikarski E,Young RA,Niveleau A,Cedar H,Simon I. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 2006; 38: 14953.
  • 33
    Ohm JE,McGarvey KM,Yu X,Cheng L,Schuebel KE,Cope L,Mohammad HP,Chen W,Daniel VC,Yu W,Berman DM,Jenuwein T, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39: 23742.
  • 34
    Widschwendter M,Fiegl H,Egle D,Mueller-Holzner E,Spizzo G,Marth C,Weisenberger DJ,Campan M,Young J,Jacobs I,Laird PW. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39: 1578.
  • 35
    Linhart HG,Lin H,Yamada Y,Moran E,Steine EJ,Gokhale S,Lo G,Cantu E,Ehrich M,He T,Meissner A,Jaenisch R. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 2007; 21: 311022.
  • 36
    Hodge DR,Xiao W,Clausen PA,Heidecker G,Szyf M,Farrar WL. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001; 276: 3950811.